Transcripts Biomea Fusion, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 12/06/2026			Varia. 5j.	Varia. 1 janv.
1,170 ^USD	-1,68%		-7,87%	-5,65%

06/06	Biomea Fusion, Inc. présente de nouvelles données cliniques et translationnelles pour l'icovamenib et annonce l'extension de l'etude de Phase I BMF-650 en cours	CI
03/06	Biomea Fusion, Inc. et l'Université de Leicester annoncent une collaboration de recherche pour évaluer l'icovamenib en association avec le sémaglutide dans l'obésité	CI

06/05	Transcript : Biomea Fusion, Inc. - Special Call
28/04	Transcript : Biomea Fusion, Inc. - Special Call
30/03	Transcript : Biomea Fusion, Inc. - Special Call
30/03	Transcript : Biomea Fusion, Inc. - Special Call
15/01	Transcript : Biomea Fusion, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 05:15 PM
23/10/25	Transcript : Biomea Fusion, Inc. Presents at Citi's 2025 SMID Cap Biopharma Call Series, Oct-23-2025 08:00 AM
07/10/25	Transcript : Biomea Fusion, Inc. - Special Call
13/03/25	Transcript : Biomea Fusion, Inc. Presents at Barclays 27th Annual Global Healthcare Conference 2025, Mar-13-2025 10:00 AM
15/01/25	Transcript : Biomea Fusion, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 01:30 PM
17/12/24	Transcript : Biomea Fusion, Inc. - Special Call
09/12/24	Transcript : Biomea Fusion, Inc. - Special Call
30/10/24	Transcript : Biomea Fusion, Inc. - Special Call
26/09/24	Transcript : Biomea Fusion, Inc. - Special Call
07/03/24	Transcript : Biomea Fusion, Inc. Presents at 17th International Conference on Advanced Technologies & Treatments for Diabetes, Mar-07-2024 10:00 AM
09/01/24	Transcript : Biomea Fusion, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 08:15 AM
07/12/23	Transcript : Biomea Fusion, Inc. Presents at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease, Dec-07-2023 through Dec-09-2023